KOPRAN
Back to All Ratios
|
KOPRAN Last 5 Year Core EBITDA Growth History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Core EBITDA Growth(%) | -13.64 | 62.27 | -44.02 | -1.77 | 110.80 |
What is the latest Core EBITDA Growth ratio of KOPRAN ?
| Year | Core EBITDA Growth |
|---|---|
| Mar2025 | -13.64 |
| Mar2024 | 62.27 |
| Mar2023 | -44.02 |
| Mar2022 | -1.77 |
| Mar2021 | 110.80 |
How is Core EBITDA Growth of KOPRAN Trending?
| Years | Core EBITDA Growth | % Change | |
|---|---|---|---|
| Mar2025 | -13.64 | Negative | |
| Mar2024 | 62.27 | Positive | |
| Mar2023 | -44.02 | Negative | |
| Mar2022 | -1.77 | Negative | |
| Mar2021 | 110.8 | - | |
Other Financial Ratios of KOPRAN
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹819.4 Cr | 1.4% | -1.6% | -47.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,248.0 Cr | 1.8% | 2.7% | -11.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,177.0 Cr | -0.6% | 7.7% | 9.4% | Stock Analytics | |
| CIPLA | ₹132,898.0 Cr | 4.9% | 6.7% | 7.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹122,428.0 Cr | 2.4% | -1% | 4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,818.0 Cr | 3.2% | -1.7% | -4.5% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | 1.4% |
-1.6% |
-47.1% |
| SENSEX | 2.4% |
2.3% |
4.4% |
You may also like the below Video Courses